Canaccord Genuity Sticks to Its Buy Rating for Merit Medical Systems (MMSI)
TipRanks (Wed, 12-Aug 7:27 AM ET)
TipRanks (Tue, 11-Aug 7:00 AM ET)
Merit Medical to Participate in Upcoming Investors Conferences in August
Globe Newswire (Wed, 5-Aug 12:00 PM ET)
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
Globe Newswire (Thu, 30-Jul 4:05 PM ET)
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
Globe Newswire (Thu, 2-Jul 4:05 PM ET)
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
Globe Newswire (Tue, 19-May 9:15 AM ET)
Merit Medical Sets Sights on Industry Growth at Bank of America Health Care Conference
Market Chameleon (Fri, 8-May 5:49 AM ET)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Merit Medical Systems trades on the NASDAQ stock market under the symbol MMSI.
As of August 12, 2026, MMSI stock price climbed to $91.20 with 725,122 million shares trading.
MMSI has a beta of 0.35, meaning it tends to be less sensitive to market movements. MMSI has a correlation of 0.02 to the broad based SPY ETF.
MMSI has a market cap of $5.45 billion. This is considered a Mid Cap stock.
Last quarter Merit Medical Systems reported $419 million in Revenue and $1.19 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.25.
In the last 3 years, MMSI traded as high as $111.45 and as low as $59.74.
The top ETF exchange traded funds that MMSI belongs to (by Net Assets): IJR, IWM, VTI, VB, VBK.
MMSI has underperformed the market in the last year with a return of +8.5%, while SPY returned +22.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MMSI shares. However, MMSI has outperformed the market in the last 3 month and 2 week periods, returning +51.2% and +16.5%, while SPY returned +4.7% and +4.3%, respectively. This indicates MMSI has been having a stronger performance recently.
MMSI support price is $89.29 and resistance is $92.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMSI shares will trade within this expected range on the day.